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Introduction
With the help of widespread health screening and develop-
ment of endoscopic technology, early detection of gastric cancer 
has been raised where gastric cancer is prevalent such as Korea and 
Japan.
1,2
 Endoscopic resection, endoscopic submucosal resection 
or endoscopic submucosal dissection has been gaining acceptance 
as a useful method to treat early gastric cancer due to its minimal 
invasiveness and favorable results in maintaining good quality of 
life.
3-6
 However, additional gastrectomy is needed after endo-
scopic resection for early gastric cancer when pathology confirms 
any possibility of lymph node metastasis or margin involvement.
7,8
While there have been several reports regarding the necessity of 
additional surgery after endoscopic resection, no studies depicted 
the optimal type of surgery to apply in these patients. Some studies 
showed successful outcomes of laparoscopic gastrectomy after en-
doscopic resection. However, most of these studies only focused on 
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short-term outcomes and not the long-term outcomes.
9-11
 Whether 
the benefits of minimally invasive surgery can be maintained and 
oncological safety of laparoscopic approach in these specific pa-
tients is not investigated. 
To the best of our knowledge, there has been no study evaluat-
ing oncologic feasibility as well as early postoperative outcomes of 
laparoscopic gastrectomy after endoscopic resection compared with 
open surgery. In this context, to identify the optimal type of gas-
trectomy we compared the long-term outcomes of surgery lapa-
roscopic gastrectomy with those of open gastrectomy for patients 
previously treated by endoscopic resection. In addition we also 
assessed the short-term outcomes whether the benefits of laparo-
scopic approach are existed in these specific patients group.
Materials and Methods
1. Patients
From January 2003 to December 2010, 139 consecutive patients 
who underwent gastrectomy with lymph node dissection either by 
laparoscopic or by open for gastric cancer after endoscopic treat-
ment, either by endoscopic mucosal resection or by endoscopic sub-
mucosal dissection, at Severance Hospital, Yonsei University Health 
System, Seoul, Korea were included in this study. Of these 139 
patients, 29 patients underwent gastrectomy because of local tumor 
recurrences in the same stomach area during follow up after com-
plete resection by endoscopically without any probability of lymph 
node metastasis. After excluding 29 recurred patients after complete 
endoscopic resection, 110 patients were included for the analyses. 
Patient demographics, pathologic feature after endoscopic treat-
ment, pathologic outcome after surgery, clinical outcomes including 
operation time, time to gas passing, time to soft diet, hospital day, 
complications and long term oncologic outcomes were compared 
between open and laparoscopic group. The written informed con-
sent was received from all of the patients at the time of surgery. 
2. Indications of surgery after endoscopic resection 
and surgical procedures 
The indications of surgery after endoscopic resection are when 
pathology reports confirms any of following conditions lateral 
margin involvement of cancer, submucosal invasion with or without 
basal margin involvement, lymph vascular invasion, and local tu-
mor recurrence after endoscopic resection.  
According to the tumor location, we performed distal subtotal 
or total gastrectomy. The lymph node dissection was performed 
according to the rules of the Japanese Research Society for Gastric 
Cancer as follows; D1+α (dissection of group 1 and number 7 lymph 
node), D1+β (dissection of group 1 and number 7, 8a, and 9 lymph 
nodes), or D2 lymphadenectomy (dissection of all group 1 and group 
2 lymph nodes).
12,13
3. Follow-up, categorization of recurrence pattern, 
and survival 
We followed up the patients every 3 months for 1 year after 
operation and every 6 months for the next 4 years with physical 
examination, laboratory tests including tumor markers (carcinoem-
bryonic antigen, carbohydrate antigen, 19-9). The chest radiogra-
phy, abdominal pelvic computed tomography and endoscopy were 
performed at least once a year. We classified the recurrence pattern 
as loco-regional, lymphatic, distant metastasis and we confirm the 
recurrence by the tissue biopsy if possible. 
The last follow up date was September 11th, 2012.
4. Statistical analysis
Statistical analysis was performed using SPSS version 18.0 for 
Windows (IBM Co., Armonk, NY, USA). Categorical variables 
were compared using chi-square or Fisher’s exact test, and con-
tinuous variables were compared with Mann-Whitney test. The 
risk factors associated with tumor recurrence and death were ana-
lyzed with univariate and multivariate logistic regression test. The 
Cox proportional hazard model was used for risk factors affecting 
disease free survival and overall survival. 
Results
1. Comparison of clinicopathologic features 
Table 1 shows the clinical characteristics and pathologic results 
of endoscopic resection of the 110 patients who received radical 
gastrectomy after endoscopic resection. Demographic features in 
terms of in age and gender between open and laparoscopic gas-
trectomy group. There were no significant differences between the 
two groups in pathologic findings of endoscopic resection, except 
location of the tumor. In laparoscopic gastrectomy group, tumor 
located more commonly in the lower third (P=0.02). 
2. Comparison of indications of radical gastrectomy
The indications of radical gastrectomy are demonstrated in Fig. 1. 
Incomplete resection is defined to presence of carcinoma at lateral 
resection margin. Presence of lymph node metastasis is defined to 
Gastrectomy after Endoscopic Procedure
53
of systemic lymph node dissection were similar between open and 
laparoscopic gastrectomy group. Mean operation time also showed 
no significant difference between the open and laparoscopic group 
(161.8 min vs. 155.1 min, P=0.80). Laparoscopic group showed sig-
nificantly shorter time to gas passing (2.7 days vs. 3.5 days, P＜0.01) 
and soft diet (4.2 days vs. 5.4 days, P＜0.01) and hospital (8.6 days 
vs. 10.6 days, P＜0.01) compared to open group. Rate of postoper-
ative complications was comparable between the two groups. There 
Fig. 1. Surgical indications and results 
of follow up according to types of sur-
gery. Open = open gastrectomy; Lap = 
laparoscopic gastrectomy; LN = lymph 
node.
submucosal invasion, histologic undifferentiation or had lympho-
vascular invasion. There were no differences in indications of ad-
ditional gastrectomy after endoscopic resection between open and 
laparoscopic resection group. 
3. Short-term postoperative outcomes 
Postoperative outcomes are summarized in Table 2. Type of 
operation (subtotal gastrectomy vs. total gastrectomy) and extent 
Table 1. Comparison of clinicopathologic features after endoscopic treatment
Characteristic Open (n=36, %) Laparoscopy (n=74, %) P-value
Age (yr) 60.3±9.8 (43~76) 60.4±10.2 (40~78) 0.99‡
Gender Male 22 (61.1) 49 (66.2) 0.38†
Female 14 (38.9) 25 (33.8)
Location Upper 9 (25.0) 9 (12.0) 0.02*
Middle 9 (25.0) 8 (10.8)
Lower 18 (50.0) 57 (77.0)
Size (mm) 12.8±5.0 (4~30) 16.8±5.0 (2~52) 0.53‡
Depth of invasion Mucosa 13 (36.1) 25 (33.8) 0.83†
Submucosa 23 (63.9) 49 (66.2)
Histology Adenoca. well diff. 11 (30.6) 29 (39.2) 0.42*
Adenoca. moderate diff. 5 (13.9) 16 (21.6)
Adenoca. poor diff. 10 (27.8) 12 (16.2)
Signet ring cell 1 (2.8) 0 (0.0)
Mucinous 8 (22.2) 15 (20.3)
Undifferentiated 1 (2.8) 2 (2.7)
Margin All free 17 (47.2) 32 (43.2) 0.98*
LM positive 9 (25.0) 19 (25.7)
BM positive 7 (19.4) 16 (21.6)
LM+BM positive 3 (8.3) 7 (9.5)
LVI Negative 30 (83.3) 60 (81.1) >0.99*
Positive 6 (16.7) 14 (18.9)
Values are presented as mean±standard deviation (range) or number (%). Adenoca. = adenocarcinoma; diff. = differentiated; LM = lateral margin; 
BM = basal margin; LVI = lymphovascular invasion. *Chi-square test. †Fisher’s exact test; ‡Mann-Whitney U tests. 
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was no mortality caused by surgical complication. 
The residual tumor was founded 55.6% in open group, and 
68.9% in laparoscopic group (P=0.20). Depth of residual tumor was 
not different between two groups (P=0.06). The metastatic lymph 
nodes were founded in 13.9% of open gastrectomy and 9.5% of 
laparoscopic group (P=0.80). The number of lymph nodes retrieved 
in the laparoscopic group did not differ from those dissected during 
the convetional open  group (P=0.46).
4. Long-term oncologic outcomes
There were 3 recurrences. All of the recurrences were distant 
metastases. Six patients died during the median follow-up period 
of 47 months. Among 6 patients, three patients died of recurred 
gastric cancer (1 in laparoscopic and 2 in open gastrectomy group) 
while but the other three patients died due to other malignancies 
of malignant lymphoma, renal pelvis cancer and breast cancer. 
There were no statistical difference in recurrence rate (1.4% for 
laparoscopic and 5.6% for open, P=0.25) and in overall (P=0.22) 
and disease-free survival (P=0.19) between the two groups (Fig. 
2). In the univariate and multivariate logistic analysis, type of ap-
proach was not an independent risk factor for recurrence (Table 3). 
In the Cox regression hazard model, T stage and N stage were the 
significant prognostic factors associated with disease free survival 
(Table 4). However, type of approach was not an independent risk 
Table 2. Comparison of short-term outcomes and pathologic results after gastrectomy
 Variable Open (n=36) Laparoscopy (n=74) P-value
Extent of resection Distal subtotal 25 (69.4) 60 (81.1) 0 .23†
Total 11 (30.6) 14 (18.9)
Extent of LN dissection ≤D1+β 30 (83.3) 55 (74.3) 0.34†
D2 6 (16.7) 19 (25.7)
Operation time (min) 161.8±66.3 155.1±50.3 0.80‡
Gas passing, mean (d) 3.5±1.0 2.7±0.7 <0.01‡
Soft diet, mean (d) 5.4±1.7 4.2±1.7 <0.01‡
Hospital stay, mean (d) 10.6±6.3 8.6±18.9 <0.01‡
Surgical complication Absent 31 (86.1) 63 (85.1) >0.99†
Present 5 (13.9) 11 (14.9)
Residual tumor Absent 16 (44.4) 23 (31.1) 0.20†
Present 20 (55.6) 51 (68.9)
Depth of residual tumor No residual 16 (44.4) 23 (31.1) 0.06*
Mucosa 7 (19.4) 22 (29.7)
Submucosa 9 (25.0) 26 (35.1)
Proper muscle 1 (2.8) 3 (4.1)
Subserosa 3 (8.3) 0 (0.0)
Nodal stage 0 31 (86.1) 67 (90.5) 0.80*
1 2 (5.6) 4 (5.4)
2 2 (5.6) 2 (2.7)
3 1 (2.8) 1 (1.4)
Number of retrieved LNs 31.6±10.9 35.1±14.1 0.16‡
   stage IA 30 (83.3) 65 (87.8) 0.47*
IB 2 (5.6) 5 (6.8)
IIA 1 (2.8) 3 (4.1)
IIB 1 (2.8) 1 (1.4)
IIIA 1 (2.8) 0 (0.0)
IIIB 1 (2.8) 0 (0.0)
Values are presented as number (%) or mean±standard deviation. LN = lymph node; *Chi-square test; †Fisher’s exact test; ‡Mann-Whitney U test. 
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factor for disease free survival of the patients underwent additional 
gastrectomy after endoscopic resection. 
Discussion
In this study, we compared the short-term postoperative out-
comes and long-term oncologic outcomes between conventional 
open and laparoscopic gastrectomy in the patients who previously 
resected with endoscopy for clinically early gastric cancer. We 
found that the short-term outcomes, such as hospital day, time to 
gas passing and time to soft diet showed favorable results in laparo-
scopic gastrectomy group. The oncologic outcomes of laparoscopic 
gastrectomy were comparable to those of conventional open gas-
trectomy. The adequate lymph node dissection and favorable long-
Table 3. Uni- and multivariate analyses of risk factors for recurrence after gastrectomy
Variable
Univariate analysis Multivariate analysis
HR (95% CI) P-value HR (95% CI) P-value
Age (≤65 year vs. >65 year)  3.60 (0.32~41.40) 0.30 3.60 (0.20~62.48) 0.38
Sex (Male vs. female) 3.78 (0.30~43.10) 0.28 2.90 (0.18~49.75) 0.45
Type of surgery (Open vs. laparoscopy) 0.23 (0.02~2.66) 0.24
Extent of resection (Subtotal vs. total) 1.73 (0.15~19.90) 0.67
Lymphovascular invasion (Absent vs. present) 2.32 (0.20~26.87) 0.50
T stage (1 vs. 2, 3) 33.67 (2.67~425.95) <0.01 11.14 (0.57~218.95) 0.11
N stage (0 vs. 1, 2, 3)  19.40 (1.61~233.32) 0.02 8.90 (0.43~188.44) 0.16
Values are presented as mean (range). HR = hazard ratio; CI = confidential interval.
Fig. 2. Comparison of disease free survival open gastrectomy. Open = 
open gastrectomy; Lap = laparoscopic gastrectomy.
Table 4. Uni- and multivariate analysis of prognostic factors for disease free survival
Variable
Univariate analysis Multivariate analysis
HR (95% CI) P-value HR (95% CI) P-value
Age (≤65 year vs. >65 year) 3.90 (0.36~43.37) 0.26 15.52 (0.52~465.40) 0.11
Sex (Male vs. female) 3.60 (0.33~39.78) 0.30 1.06 (0.06~17.60) 0.96
Type of surgery (Open vs. laparoscopy) 0.23 (0.02~2.54) 0.23
Extent of resection (Subtotal vs. total) 1.65 (0.15~18.20) 0.68
Extent of LN dissection (D1+ β vs. D2) 0.03 (0.00~3,561.80) 0.57
Histology (Diff. vs. undiff.) 79.20 (0.00~908,347) 0.36 11.14 (0.57~218.95) 0.11
Submucosal invasion (Absent vs. present) 40.17 (0.00~797,543) 0.47 8.90 (0.43~188.44) 0.16
Lymphovascular invasion (Absent vs. present) 2.16 (0.20~23.84) 0.53
Size (<25 mm vs. ≥25 mm) 0.03 (0.00~1,813.67) 0.53
T stage (1 vs. 2, 3) 31.15 (2.82~343.89) <0.01 17.17 (1.17~251.93) 0.04
N stage (0 vs. 1, 2, 3) 18.28 (1.66~201.63) 0.02 24.78 (0.97~633.74) 0.04
Values are presented as mean (range). HR = hazard ratio; CI = confidential interval.
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term outcomes, measured by disease free survival and recurrence 
were achieved by laparoscopic surgery for patients previously treat 
by endoscopic resection.  
Endoscopic resection has been established as one of treatment 
options for early gastric cancer. Endoscopic resection provides a 
survival rate of 90% comparable to that of surgery if it is applied 
with appropriate indications.
14-16
 It also can avoid morbidity and 
mortality associated with surgery and maintain the patients’ quality 
of life after treatment. However, additional gastrectomy is needed 
after endoscopic resection for early gastric cancer when pathology 
confirmed any possibility of lymph node metastasis or margin in-
volvement.
7-11
 While there have been several reports regarding the 
necessity of additional surgery after endoscopic resection, no stud-
ies depicted the optimal type of surgery to apply in these patients.
Laparoscopic gastrectomy for gastric cancers has been widely 
used for early gastric cancer. This approach increased because of 
its low invasiveness, good cosmesis and recovery.
17-19
 Although 
there are some unresolved oncologic problems for advanced gastric 
cancer, in early gastric cancer, laparoscopic gastrectomy is con-
sidered to be safe, and the rate of local failure after laparoscopic 
gastrectomy is comparable to that of open surgery.
20-22
 Applications 
of laparoscopic gastrectomy for patients previously received en-
doscopic resection in early gastric cancer have been reported. But, 
these studies were focused on that laparoscopic surgery might be 
beneficial in regard to short term clinical outcome after surgery.  
According to our results, oncologic outcomes of laparoscopic 
gastrectomy were comparable with those of conventional open 
gastrectomy in the patients who previously received endoscopic 
resection for gastric cancer. The favorable long-term outcomes, 
measured by disease free survival and recurrence were achieved 
by laparoscopic surgery. Also, D2 lymph node dissection was per-
formed in laparoscopic gastrectomy similar to open surgery. The all 
of recurrences were distant metastases, which means that adequate 
local control was achieved by laparoscopic gastrectomy. The com-
plication rates were also acceptable compared to open surgery and 
there was no mortality. 
There are some important concerns of the long-term onco-
logic outcomes of laparoscopic gastrectomy. The first issue is the 
potential peritoneal recurrence or port site metastasis due to in-
sufflated gas  for a pneumoperitoneum. In our study, there were 
neither port-site metastases nor recurrence at surgical wound. The 
peritoneal recurrence occurred only in one patient of laparoscopic 
group. The second is the possible loco-regional recurrence because 
of inadequate lymph node dissection. However, our study revealed 
that D2 dissection was performed similarly in two groups and 
the number of retrieved lymph nodes in laparoscopic surgery was 
comparable to that of open surgery. However, the study is limited 
by the retrospective nature of analyses and possibility of selection 
bias of applying laparoscopic surgery. Despite these limitations, 
we analyzed 110 gastric cancer patients who received endoscopic 
resection before radical gastrectomy and compared the long term 
oncologic outcome between laparoscopic and open surgery.
In conclusion, our study demonstrated that laparoscopic ap-
proach can be safely applied for gastric cancer patients previously 
treated by endoscopic resection. Laparoscopic gastrectomy after 
endoscopic resection showed comparable oncologic outcomes to 
open approach while maintaining benefits of minimally invasive 
surgery. Thus, laparoscopic gastrectomy can be a treatment of 
choice for patients previously treated by endoscopic resection.
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